In the studies included in our research on the relationship between TLS and FOXP3 expression levels, there were 1 colorectal cancer study, 2 hepatocellular carcinoma studies, and 1 pancreatic cancer study, all of which showed significant heterogeneity. This evidence concerns the gene FOXP3 and pancreatic neoplasm.